Conversation with GS1 to be Released January 22nd – Next Level Supply Chain Podcast
January 17, 2025

Conversation with GS1 to be Released January 22nd – Next Level Supply Chain Podcast

Gateway Checker founder and president Gary Lerner recently had the opportunity to speak on the Next Level Supply Chain Podcast, hosted by GS1 US. His conversation focused on DSCSA guidelines and their benefits on the supply chain, best practices for conformance, and tons more. The episode will be released on January 22nd—to watch the full […]
Read More
Trump’s Tariffs and Drug Prices
December 11, 2024

Trump’s Tariffs and Drug Prices

Following his election victory, president-elect Donald Trump announced intentions of implementing tariffs on Canada, Mexico, and China; these tariffs include 25% tax on imports from both Mexico and Canada, and an additional 10% increase on the tariffs already in place on Chinese exports to the United States. The goals of these imports, according to the […]
Read More
What Isn’t Included in the Recent Exemption
November 27, 2024

What Isn’t Included in the Recent Exemption

Published November 26th, 2024 Who Does It Apply To? Recently, I shared that eligible trading partners were temporarily exempted from specific components of the Drug Supply Chain Security Act, “Latest DSCSA Exemption”. However, considering the stabilization period ends tomorrow, I thought I’d share some further insights on what isn’t part of the recent exemption. First, […]
Read More
So, You Think You’re Exempt
November 22, 2024

So, You Think You’re Exempt

DSCSA Deadline: Just Days Away The deadline for DSCSA stabilization is just days away, mandating Enhanced Drug Distribution Security (EDDS) requirements for manufacturers, repackagers, wholesale distributors, and dispensers. While the FDA announced an extension from certain components of the FD&C in the form of a phased approach, this extension only applies to certain eligible trading […]
Read More
What Is Exempt, per recent DSCSA Update 
November 22, 2024

What Is Exempt, per recent DSCSA Update 

According to the DSCSA Exemption Announcement from the FDA on October 9th, here are the specific components of the legislation that eligible trading partners are exempt from.  Section 582(g)(1)(A-F) for Manufacturers and Repackagers, Wholesale distributors, and Dispensers  ‘‘(A) The transaction information and the transaction statements as required under this section shall be exchanged in a […]
Read More